XML 23 R50.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation Plans (Summary Of Stock Option Activity) (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
6 Months Ended 12 Months Ended
Jun. 30, 2012
Dec. 31, 2011
Outstanding, beginning balance, shares 3.9  
Outstanding, beginning balance, weighted average exercise price $ 23.90  
Outstanding, beginning balance weighted average remaining contractual term 5 years 8 months 12 days 2 years 1 month 1 day
Outstanding, beginning balance, weighted average fair value at date of grant $ 4.20 $ 10.17
Exercisable, beginning balance, shares 3.2  
Exercisable, beginning balance, weighted average exercise price $ 25.97  
Exercisable, beginning balance, weighted average remaining contractual term 1 year 4 months 24 days 8 months 12 days
Exercisable, beginning balance, weighted average fair value at grant date $ 9.15  
Granted, shares 0.7  
Granted, weighted average exercise price $ 12.79  
Granted, weighted average remaining contractual term 9.6  
Granted, weighted average fair value at date of grant $ 3.43  
Exercised, shares (0.5)  
Exercised, weighted average exercise price $ 11.69  
Forfeited/cancelled, shares (2.0)  
Forfeited/cancelled, weighted average exercise price $ 34.39  
Outstanding, ending balance, shares 2.1 3.9
Outstanding, ending balance, weighted average exercise price $ 12.74 $ 23.90
Outstanding, ending balance weighted average remaining contractual term 5 years 8 months 12 days 2 years 1 month 1 day
Outstanding, ending balance, weighted average fair value at date of grant $ 4.20 $ 10.17
Exercisable, ending balance, shares 0.9 3.2
Exercisable, ending balance, weighted average exercise price $ 12.04 $ 25.97
Exercisable, ending balance, weighted average remaining contractual term 1 year 4 months 24 days 8 months 12 days
Exercisable, ending balance, weighted average fair value at grant date $ 4.79 $ 9.15
Stock Options [Member]
   
Outstanding, beginning balance, weighted average fair value at date of grant $ 3.43  
Granted, weighted average exercise price $ 12.79  
Outstanding, ending balance, weighted average fair value at date of grant $ 3.43